RE-BVS – Piemonte Repository

Sfoglia per AUTORE
CAMELI P
Collezione AO Ordine Mauriziano

Items : 7

Dupilumab Effectiveness in Patients with Severe Allergic Asthma Non-Responsive to Omalizumab. in Journal of personalized medicine / J Pers Med. 2025 Jan 23;15(2):43. doi: 10.3390/jpm15020043.

2025
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Fedele S; Bertolini M; Canevari RF; Caruso C; Senna G; Caminati M; Pini L; Spanevello A; Visca D; Gollinucci C; Guida G; Tiotiu A; Cameli P; Nicola S; Brussino L; Bondi B; Bagnasco D; Mincarini M; Canonica GW; Braido F; On Behalf Of The Sani Group;

Profiling Blood Hypereosinophilia in Patients on Dupilumab Treatment for Respiratory Conditions: A Real-Life Snapshot. in The journal of allergy and clinical immunology. In practice / J Allergy Clin Immunol Pract. 2025 Feb 14:S2213-2198(25)00165-5. doi: 10.1016/j.jaip.2025.01.040.

2025
AO Ordine Mauriziano

Caminati M; Maule M; Bagnasco D; Beghè B; Braido F; Brussino L; Cameli P; Candeliere MG; Carpagnano GE; Costanzo G; Crimi C; D'Amato M; Del Giacco S; Guarnieri G; Yacoub MR; Micheletto C; Moletta F; Nicola S; Olivieri B; Pini L; Schiappoli M; Scarpieri E; Vaia R; Vianello A; Visca D; Spanevello A; Senna G; Benoni R;

Dupilumab Efficacy on Asthma Functional, Inflammatory, and Patient-Reported Outcomes across Different Disease Phenotypes and Severity: A Real-Life Perspective. in Biomedicines / Biomedicines. 2024 Feb 8;12(2):390. doi: 10.3390/biomedicines12020390.

2024
AO Ordine Mauriziano

Caminati M; Maule M; Benoni R; Bagnasco D; Beghè B; Braido F; Brussino L; Cameli P; Candeliere MG; Carpagnano GE; Costanzo G; Crimi C; D'Amato M; Del Giacco S; Guarnieri G; Yacoub MR; Micheletto C; Nicola S; Olivieri B; Pini L; Schiappoli M; Vaia R; Vianello A; Visca D; Spanevello A; Senna G;

Sustained Effectiveness of Benralizumab in Naïve and Biologics-Experienced Severe Eosinophilic Asthma Patients: Results from the ANANKE Study. in Journal of asthma and allergy / J Asthma Allergy. 2024 Mar 27;17:273-290. doi: 10.2147/JAA.S438981. eCollection 2024.

2024
AO Ordine Mauriziano

Cameli P; Aliani M; Altieri E; Bracciale P; Brussino L; Caiaffa MF; Canonica GW; Caruso C; Centanni S; D'Amato M; De Michele F; Del Giacco S; Di Marco F; Pelaia G; Rogliani P; Romagnoli M; Schino P; Schroeder JW; Senna G; Vultaggio A; Benci M; Boarino S; Menzella F;

Long-term effectiveness of benralizumab in severe eosinophilic asthma patients treated for 96-weeks: data from the ANANKE study. in Respiratory research / Respir Res. 2023 May 20;24(1):135. doi: 10.1186/s12931-023-02439-w.

2023
AO Ordine Mauriziano

Vultaggio A; Aliani M; Altieri E; Bracciale P; Brussino L; Caiaffa MF; Cameli P; Canonica GW; Caruso C; Centanni S; D'Amato M; De Michele F; Del Giacco S; Di Marco F; Menzella F; Pelaia G; Rogliani P; Romagnoli M; Schino P; Senna G; Benci M; Boarino S; Schroeder JW;

Clinical Features and Efficacy of Benralizumab in Patients with Blood Eosinophil Count Between 300 and 450 Cells/mm(3): A Post Hoc Analysis from the ANANKE Study. in Journal of asthma and allergy / J Asthma Allergy. 2022 Nov 10;15:1593-1604. doi: 10.2147/JAA.S383012. eCollection 2022.

2022
AO Ordine Mauriziano

Senna G; Aliani M; Altieri E; Bracciale P; Brussino L; Caiaffa MF; Cameli P; Canonica GW; Caruso C; D'Amato M; De Michele F; Del Giacco S; Di Marco F; Menzella F; Pelaia G; Rogliani P; Romagnoli M; Schino P; Schroeder JW; Vultaggio A; Rizzoli S; Zullo A; Boarino S; Palmisano M; Rossi A; Vitiello G; Centanni S;

Switching from one biologic to benralizumab in patients with severe eosinophilic asthma: An ANANKE study post hoc analysis. in Frontiers in medicine / Front Med (Lausanne). 2022 Sep 2;9:950883. doi: 10.3389/fmed.2022.950883. eCollection 2022.

2022
AO Ordine Mauriziano

Caruso C; Cameli P; Altieri E; Aliani M; Bracciale P; Brussino L; Caiaffa MF; Canonica GW; Centanni S; D'Amato M; Del Giacco S; De Michele F; Pastorello EA; Pelaia G; Rogliani P; Romagnoli M; Schino P; Caminati M; Vultaggio A; Zullo A; Rizzoli S; Boarino S; Vitiello G; Menzella F; Di Marco F;